<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0004" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name name-style="western" class="name">
    <surname class="surname">Edelman</surname>
    <given-names class="given-names">R</given-names>
   </name>, 
   <name name-style="western" class="name">
    <surname class="surname">Assaraf</surname>
    <given-names class="given-names">YG</given-names>
   </name>, 
   <name name-style="western" class="name">
    <surname class="surname">Levitzky</surname>
    <given-names class="given-names">I</given-names>
   </name>, 
   <etal class="etal">et al</etal>
  </person-group> (
  <year class="year">2017</year>). 
  <article-title class="article-title">Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy</article-title>. 
  <source class="source">Oncotarget</source>
  <volume class="volume">8</volume>:
  <fpage class="fpage">24337</fpage>–
  <lpage class="lpage">53</lpage>.
  <pub-id pub-id-type="pmid" class="pub-id">28212584</pub-id>
 </mixed-citation>
</ref>
